United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jul 14, 2026 · Filed Jul 15, 2026

On Jul 14, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$526.83 for US$5M under a trading plan, leaving 40,513 shares. Filed Jul 15, 2026 (Form 4).

Sold
9,500 shares
Price
US$526.83 average (US$524.15 to US$532.60)
Value
US$5M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 14, 2026Common StockOption exercise9,500US$135.4250,013Direct
Jul 14, 2026Common StockSale840US$524.1549,173Direct
Jul 14, 2026Common StockSale1,468US$525.1647,705Direct
Jul 14, 2026Common StockSale3,492US$526.1344,213Direct
Jul 14, 2026Common StockSale1,220US$527.0642,993Direct
Jul 14, 2026Common StockSale660US$528.1342,333Direct
Jul 14, 2026Common StockSale959US$529.2141,374Direct
Jul 14, 2026Common StockSale554US$530.6740,820Direct
Jul 14, 2026Common StockSale107US$531.0840,713Direct
Jul 14, 2026Common StockSale200US$532.6040,513Direct

Source

View original at SEC

Related